Stop Wasting Hours on
Pharmaceutical Documentation

The pharmaceutical industry operates under the strictest documentation requirements of any sector. Every drug, excipient, and medical compound requires extensive documentation for regulatory submission, manufacturing, distribution, and post-market surveillance. A single documentation error can delay a drug launch by months, trigger FDA warning letters, or result in costly product recalls. Documentation in pharma isn't optional — it's the foundation of patient safety.

Pharmaceutical documentation must comply with FDA 21 CFR Part 211 (Current Good Manufacturing Practice), ICH guidelines for stability testing and validation, EU GMP Annex requirements, and GHS regulations for chemical safety data sheets. Drug Master Files (DMFs), Investigational New Drug (IND) applications, and New Drug Applications (NDAs) each require hundreds of pages of meticulously structured documentation with precise formatting and cross-references.

SpecIQ helps pharmaceutical teams generate compliant documentation drafts in minutes rather than weeks. While final regulatory submissions always require expert review, SpecIQ accelerates the initial drafting process by 10x — producing properly structured SDS documents, technical data sheets, and compliance reports that follow industry-standard section ordering and terminology. Teams spend their time reviewing and refining rather than writing from scratch.